-
Extraordinary general meeting to approve capital reduction (without payment) to cover accumulated deficits, to be held on June 9, 2026. Record date: May 12, 2026. -
Board resolution date: April 27, 2026, with all 2 outside directors present.
Extraordinary General Meeting to Approve Capital Reduction for Deficit Coverage
KOSDAQ Filing Information
- Resolution to Convene a General Meeting of Shareholders (Extraordinary General Meeting)
- Company: NGeneBio (354200)
- Submission: NGeneBio Co., Ltd.
- Under KRX KOSDAQ Market Division
- Shares: 26,809,750
- Price: 1,687 KRW
- Market Cap: 45.2 B KRW